The stewardship and oversight of the affairs, business, and effective management of the IGI are the responsibility of the IGI Governance Board, a group of groundbreaking thinkers with broad experience in biological sciences and the leadership of dynamic institutions.
For inquiries about the IGI Governance Board, please contact Zilose Lyons at firstname.lastname@example.org.
Jennifer Doudna, Ph.D.
Founder and President, Innovative Genomics Institute; Professor of Molecular and Cell Biology and Chemistry, UC Berkeley. (Board Chair)
Steven Altschuler, M.D.
Managing Director of Healthcare Ventures at Ziff Capital Partners, CEO and board chair at Corner Therapeutics, and co-founder of Spark Therapeutics (now part of Roche).
Katherine High, M.D.
Professor of Pediatrics Emerita, Perelman School of Medicine of the University of Pennsylvania.
Reed Jobs is the Managing Director of the Health Team of Emerson Collective, a social change focused family office based in Palo Alto.
Daniel Lowenstein, M.D.
Professor of Neurology, Executive Vice Chancellor and Provost, UCSF.
Edward Penhoet, Ph.D.
Associate Dean of Biological Sciences and Professor Emeritus of Molecular and Cell Biology, UC Berkeley.
Robert Tjian, Ph.D.
Li Ka Shing Chancellor’s Chair in Biology, Department of Molecular and Cell Biology, UC Berkeley; Howard Hughes Medical Institute Investigator.
Mike Botchan, Ph.D.
Deputy Director, Innovative Genomics Institute; Dean of Biological Sciences Division, UC Berkeley. (Non-Voting Member)